Sign Up to like & get
recommendations!
0
Published in 2022 at "Chirality"
DOI: 10.1002/chir.23501
Abstract: We previously demonstrated that natural product-inspired 3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-ones derivatives delivered potent and selective PIM kinases inhibitors however with non-optimal ADME/PK properties and modest oral bioavailability. Herein, we describe a structure-based scaffold decoration and a stereoselective approach…
read more here.
Keywords:
synthesis dihydropyrrolo;
dihydropyrrolo pyrazin;
pyrazin one;
synthesis ... See more keywords